>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
沐舒坦预处理对大鼠急性肺损伤的肺保护作用研究
作者:徐忠能  薛涛 
单位:东南大学附属中大医院 胸外科, 江苏 南京 210009
关键词:急性肺损伤 急性呼吸窘迫综合征 沐舒坦 盐酸吸入 大鼠 
分类号:R-33;R965
出版年·卷·期(页码):2014·33·第四期(468-473)
摘要:

目的:研究不同剂量沐舒坦对大鼠急性肺损伤(ALI)的肺保护作用。方法:将40只SD大鼠随机分成5组,每组8只:生理盐水组(吸入生理盐水)、稀盐酸组(吸入稀盐酸)、稀盐酸吸入+沐舒坦低剂量处理组[吸入稀盐酸+沐舒坦(10 mg·kg-1·d-1)]、稀盐酸吸入+沐舒坦中剂量处理组[吸入稀盐酸+沐舒坦(20 mg·kg-1·d-1)]、稀盐酸吸入+沐舒坦高剂量处理组[吸入稀盐酸+沐舒坦(40 mg·kg-1·d-1)]。稀盐酸吸入+沐舒坦低、中、高剂量处理组分别予相应剂量沐舒坦行尾静脉注射,生理盐水及稀盐酸组予等体积的生理盐水行尾静脉注射,每天1次,连续3 d。在第3天尾静脉注射沐舒坦或生理盐水30 min后,生理盐水组以1.2 ml·kg-1生理盐水经气管注入,制作假盐酸吸入急性肺损伤模型作为对照;稀盐酸组、稀盐酸吸入+沐舒坦低、中、高剂量处理组则以1.2 ml·kg-1稀盐酸(pH=1.2)行气管内注入,制作盐酸吸入急性肺损伤模型。大鼠建模6 h后查动脉血气,测肺湿干重比(W/D),光镜下观察肺组织病理改变,测血清TNF-α、IL-10水平。结果:(1)光镜下组织病理学观察发现,生理盐水组肺损伤最轻,稀盐酸组肺损伤最严重,稀盐酸吸入+沐舒坦低、中、高剂量处理组的肺损伤介于生理盐水组和稀盐酸组之间,且肺损伤程度与沐舒坦剂量呈负相关;(2)与生理盐水组相比:稀盐酸组,稀盐酸吸入+沐舒坦低、中、高剂量处理组大鼠肺W/D 值、血清TNF-α、IL-10水平明显增高(均P<0.05),PaO2明显下降(均P<0.05);PaCO2稀盐酸组明显增高(P<0.05),稀盐酸吸入+沐舒坦低、中、高剂量处理组则无明显差异(P>0.05);(3)稀盐酸吸入+沐舒坦低、中、高剂量处理组与稀盐酸组相比,肺W/D 值、PaCO2、血清中TNF-α明显下降(均P<0.05),PaO2、血清中IL-10水平明显增高(均P<0.05);(4)稀盐酸吸入+沐舒坦低、中、高剂量处理组之间比较:随着沐舒坦剂量的递增,肺W/D 值、血清中TNF-α含量逐渐降低,PaO2、血清中IL-10逐渐增高;沐舒坦低剂量组与沐舒坦中剂量组、沐舒坦低剂量组与沐舒坦高剂量组之间差异有统计学意义(P<0.05);沐舒坦中、高剂量两组之间无显著差异(P>0.05),沐舒坦低、中、高剂量组之间PaCO2差异无统计学意义(P>0.05)。结论:静脉应用大剂量沐舒坦预处理能有效减轻大鼠急性肺损伤的程度,且在一定剂量范围内,沐舒坦肺保护作用与其剂量呈正相关。

Objective: To investigate the protective effect of different dose of Ambroxol against Hcl-induced acute lung injury in rats. Methods: Fouty pathogen-free SD rats were randomly divided into five groups: saline group(n=8): (saline inhalation), Hcl group(n=8)(Hcl inhalation), Hcl with low-dose of Ambroxol treatment group(n=8)[Hcl inhalation+Ambroxol(10 mg·kg-1·d-1)], Hcl with middle-dose of Ambroxol treatment group(n=8)[Hcl inhalation+Ambroxol(20 mg·kg-1·d-1)], Hcl with high-dose of Ambroxol treatment group(n=8)[Hcl inhalation+Ambroxol(40 mg·kg-1·d-1)]; Treatment groups were respectively injected with corresponding dosage of Ambroxol, saline group and Hcl group with normal saline, once a day for 3 consecutive days. On the third day, rats were received intratracheal instillation of normal saline(saline group, pH 5.3, 1.2 ml·kg-1) or hydrochloric acid/NS(Hcl group and treatment groups, pH 1.2,1.2 ml·kg-1). Six hours later, the arterial gas was examined, the contents of TNF-α and IL-10 in the blood were assayed respectively, the extent of lung injury was further assessed by measuring the ratio of wet to dry weight and evaluating histological change of tissue slice under a light microscope..Results:(1) The most severe pathologic changes were detected in Hcl group, the extent of lung injury of Ambroxol treatment groups were less severe, but more severe than saline group. Among treatment groups, the pathologic changes of Hcl with low-dose of Ambroxol treatment group was the most serious, the extent of lung injury of Hcl with middle-dose of Ambroxol treatment group was less serious, but more serious than that of Hcl with high-dose of Ambroxol treatment group. (2)Compared with saline group, the W/D ratio and TNF-α, IL-10 content in blood of Hcl group and treatment groups were obviously higher(all P<0.05), while the PaO2 was reduced(all P<0.05). The PaCO2 of Hcl group was obviously higher than that of saline group(P<0.05), while there was no difference between saline group and treatment groups(P>0.05). (3)Compared with Hcl group, the W/D ratio, PaCO2 and TNF-α in blood of treatment groups were reduced (all P<0.05), while the PaO2 and IL-10 content in blood were higher (all P<0.05). (4)Comparison among treatment groups, the W/D ratio and TNF-α in blood were lower with the increasing dosage of Ambroxol, while the PaO2 and IL-10 content in blood were higher. There was a significant difference between Hcl with low-dose of Ambroxol treatment group and Hcl with middle-dose of Ambroxol treatment group, as well as Hcl with low-dose of Ambroxol treatment group and Hcl with high-dose of Ambroxol treatment group (P< 0.05), but the difference between Hcl with middle-dose of Ambroxol treatment group and Hcl with high-dose of Ambroxol treatment group was not significant (P>0.05). The PaCO2 was higher with the increasing dosage of Ambroxol, while there was no significant difference among treatment groups(P>0.05).Conclusion: Ambroxol can obviously reduce the extent of acute lung injury induced by Hcl, and within a certain range of dosage, the lung protective effect and dosage of Ambroxol are positively correlated.

参考文献:

[1] MAYBAUER M O,MAYBAUER D M,HERNDON D N. Incidence and outcomes of acute lung injury[J].N Engl J Med,2006,354(4):416-417.
[2] RAGHAVENDRAN K,NEMZEK J,NAPOLITANO L M,et al.Aspiration-induced lung injury[J].Crit Care Med,2011,39(4):818-826.
[3] PARK N H,HAN E S,LEE C S.The inhibitory effect of ambroxol on respiratory burst,degranulation and cytosolic Ca2+change in degraded immunoglobulin G-activated neutrophils[J].Pharmacol Toxicol,1999,84(2):81-87.
[4] PFEIFER S,ZISSEL G,KIENAST K,et al.Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol[J].Eur J Med Res,1997,2(3):129-132.
[5] GILLISSEN A,NOWAK D.Characterization of N-acet-ylcysteine and ambroxol in anti-oxidant therapy[J].Respir Med,1998,92(4):609-623.
[6] 夏文超,韩兴鹏,韩洪利,等.不同剂量沐舒坦对肺癌术后患者的肺保护效果探讨[J].重庆医学,2012,41(17):1759-1760.
[7] NADER N D,KNIGHT P R,BOBEIA I,et al.High dose nitric oxide inhalation increases lung injury after gastric aspiration[J].Anesthesiology,1999,91(3):741-749.
[8] KENNEDY T P,JOHNSON K J,KUNKEL R G,et al.Acute acid aspiration lung injury in the rat: biphasic pathogenesis[J].Anesth Analg,1989,69(1):87-92.
[9] NADER-DJALAL N,KNIGHT P R 3rd,THUSU K,et al.Reactive oxygen species contribute to oxygen-related lung injury after acid aspiration[J].Anesth Analg,1998,87(1):127-133.
[10] GOODMAN R B,PUGIN J,LEE J S,et al.Cytokine-mediated inflammation in acute lung injury[J].Cytokine Growth Factor Rev,2003,14(6):523-535.
[11] FARKHUTDINOV U R, FARKHUTDINOV R R, PETRIAKOV V V, et al. Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease[J]. Ter Arkh,2010,82(3):29-32.
[12] 董硕,张春芳.沐舒坦临床应用剂量规范化探讨[J].实用药物与临床,2012,15(5):301-302.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414051 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364